Table 2 Tomotherapy® plan characteristics
Pat | Treatment session | Plan | Duration (min) | N. rotations | N. fractions | Number of PTV sub-volumes used in optimization | Number of region at risk used in optimization |
|---|---|---|---|---|---|---|---|
#1 | Upper Hemibody | #1Â U1 | 22.6 | 45.3 | 3 | 56 | 33 |
#1Â U2 | 22.6 | 43.7 | 12 | 56 | 25 | ||
Lower Hemibody | #1Â L1 | 23.6 | 19 | 10 | 14 | 14 | |
#1Â L2 | 23.6 | 19 | 3 | 14 | 14 | ||
#2 | Upper Hemibody | #2Â U1 | 27.1 | 56 | 8 | 59 | 27 |
#2Â U2 | 28.9 | 56 | 8 | 68 | 28 | ||
Lower Hemibody | #2Â L1 | 40.0 | 50.1 | 3 | 45 | 35 | |
#2Â L2 | 40.0 | 50.1 | 13 | 46 | 34 | ||
#3 | Upper Hemibody | #3Â U1 | 27.2 | 52.7 | 3 | 61 | 45 |
#3Â U2 | 27.2 | 52.7 | 13 | 74 | 56 | ||
Lower Hemibody | #3Â L1 | 29.4 | 83.9 | 15 | 71 | 42 |